NEUROPHET
5
3
3
1
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
0.0%
0 terminated/withdrawn out of 5 trials
100.0%
+13.5% vs industry average
0%
0 trials in Phase 3/4
0%
0 of 1 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (5)
Personalized rTMS Protocol Based on Functional Reserve to Enhance Ambulatory Function in PD Patients
Role: collaborator
Efficacy of Personalized Repetitive Transcranial Magnetic Stimulation Protocol Based on Functional Reserve to Enhance Upper Limb Function in Subacute Stroke Patients
Role: collaborator
Clinical Trial on the Safety and Efficacy of Optimized Transcranial Direct Current Stimulation for the Swallowing Function in Patients With Post-Stroke Dysphagia
Role: lead
AI-based Customized tDCS for Finger Motor Recovery After Subacute Stroke
Role: lead
Evaluation of SCALE PET Software for Quantitative Brain PET Analysis in Alzheimer's Disease
Role: lead
All 5 trials loaded